Morningstar
•
Sep 03, 2026
Repligen Corporation: Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier
Summary
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Alnylam Pharmaceuticals, Inc.
Sep 02, 2026
•
ALNY
GMED: Lowering target price to $89.00
Sep 02, 2026
•
GMED
NBIX: Raising target price to $172.00
Sep 02, 2026
•
NBIX
IDXX: Lowering target price to $600.00
Sep 02, 2026
•
IDXX
LGND: Raising target price to $313.00
Sep 02, 2026
•
LGND
